Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615 1624 1631 1655
This examiner grants 28% of resolved cases
Ngoc-Anh Thi Nguyen works in Art Unit 1615 of Tech Center 1600. The examiner has 64 resolved cases with an allowance rate of 28.1%. This rate indicates the proportion of applications that are granted. The 64 cases provide the foundation for this statistical analysis.
The median days to allowance is 1259. This figure represents the time required for applications to reach a grant. Practitioners can use the 1259-day median to forecast the length of the prosecution process. This duration is a consistent metric across the 64 resolved cases.
The interview lift for this examiner is 49.8%. This lift shows the change in the probability of allowance when an interview is conducted relative to the 28.1% baseline. An interview may be a strategic choice to navigate the 1259-day timeline. These figures together define the prosecution profile in Art Unit 1615.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18081915 | COSMETIC COMPOSITION COMPRISING VITAMIN B3 COMPOUND AND LAUROYL LYSINE | Final Rejection | The Procter & Gamble Company |
| 17424109 | SALT NANOPARTICLES AND COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18486054 | Systems and Methods for Assessment of Lipid Membrane-Associated Molecule Kinetics, Dynamics, and Interactions | Non-Final OA | California Institute of Technology |
| 18281115 | USE OF TAMOXIFEN AND RELATED COMPOUNDS TO REDUCE BREAST IMPLANT CAPSULE FORMATION AND CAPSULAR CONTRACTURE | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 18853279 | IMPROVEMENT OF THE WATER RESISTANCE OF COSMETIC COMPOSITIONS COMPRISING UV FILTERS | Non-Final OA | DSM IP Assets B.V. |
| 17641124 | COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULES | Final Rejection | Purdue Research Foundation |
| 18704688 | COMPOSITION COMPRISING A SPECIFIC OXIDATION DYE PRECURSOR AND TWO SPECIFIC ACIDS | Non-Final OA | L'OREAL |
| 17433289 | TRANSDERMAL PATCH | Final Rejection | HISAMITSU PHARMACEUTICAL CO., INC. |
| 17613783 | MONOSACCHARIDE-TAGGED NANO-LIPOSOME DRUG DELIVERY SYSTEM, THE MANUFACTURE AND USE FOR DRUG TARGETING DELIVERY THEREOF | Final Rejection | National Yang Ming Chiao Tung University |
| 18293033 | A COMPOSITE SYSTEM FOR AGRICULTURE | Non-Final OA | UPL LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy